# Study of Roxadustat in the Treatment of Acute Myocardial Infarction

Study · id `cardio:ct-nct04803864` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04803864](<https://clinicaltrials.gov/study/NCT04803864>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04803864

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.

## Technical summary

Registry record NCT04803864. Randomized; single masking; primary purpose treatment. Start 2021-06-10 (actual); primary completion 2022-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 158 participants (planned count; ClinicalTrials.gov record NCT04803864, source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)
- Started: 2021-06-10 (actual) (ClinicalTrials.gov record NCT04803864, source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)
- Primary completion: 2022-09-30 (anticipated) (ClinicalTrials.gov record NCT04803864, source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)
- Completion: 2023-08-31 (anticipated) (ClinicalTrials.gov record NCT04803864, source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04803864, source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04803864-2021-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Roxadustat in the Treatment of Acute Myocardial Infarction
- Acronym: ROXAMI
- Condition: ST Elevation Myocardial Infarction
- Intervention (Drug): Roxadustat
- Lead sponsor: Ruijin Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Ruijin Hospital (`cardio:org-ruijin-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Roxadustat Treatment After PCI Among Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial (`cardio:pubmed-42853570`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 600903d35da212b01407929faf61b2b67de6a1ca0b5f0e4617cec1ebf4cecdc6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
